Results 181 to 190 of about 5,668,323 (316)

PB2452: PREVALENCE AND SEVERITY OF COVID-19 IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION PATIENTS IN CHINA

HemaSphere, 2023
Hongye Gao, Jiali Wang, Xinhui Zheng, Yigeng Cao, Aiming Pang, Erlie Jiang   +5 more
doaj   +1 more source

Role of Respiratory Viral Infections in Airflow Obstruction After Hematopoietic Cell Transplantation. [PDF]

Pediatr Transplant
Pardasani SA, Suliman AY, Ferrolino JA, Dallas RH, Peterson M, Merritt P, Cole A, Davis A, Gowen A, Allison KJ, Hayden RT, Li Y, Keerthi D, Srinivasan S, Maron GM, Trilplett BM, Hijano DR.   +16 more
europepmc   +1 more source

A practical difference from the normal approach to evaluate natural killer (NK) cells and NK cell neoplasms by flow cytometry

Cytometry Part B: Clinical Cytometry, EarlyView.
Abstract Natural killer (NK) cell neoplasms span indolent to highly aggressive entities, and flow cytometric immunophenotyping is central to their detection and classification. However, distinguishing reactive from neoplastic NK cell expansions can be challenging because NK cells lack somatically recombined antigen receptors, and reactive states may ...
Aaron J. Wilk, Afshin Shameli, Erik Ames, Jonathan R. Fromm, Bartosz Grzywacz, Min Shi, Sindhu Cherian, Jean Oak   +7 more
wiley   +1 more source

Outcomes of Hematopoietic Cell Transplantation in Patients with Plasmablastic Lymphoma. [PDF]

Transplant Cell Ther
Al-Juhaishi T, Ahn KW, Chen T, Patel KK, Patel J, Herrera AF, Turtle CJ, Rizzo JD, Khimani F, Awan FT, Gibran-Nunes F, Ahmed G, Baird J, Lekakis LJ, Shadman M, Shafey M, Reidell PA, Merryman RW, Hamadani M, Ahmed S.   +19 more
europepmc   +1 more source

Subset‐specific and tissue‐specific expression of NK‐cell markers and killer immunoglobulin‐like receptors: Implications for NK‐cell clonality assessment

Cytometry Part B: Clinical Cytometry, EarlyView.
Abstract Accurate immunophenotypic evaluation of natural killer (NK)‐cell neoplasms is challenging because NK‐cells lack somatically rearranged antigen receptors, are comprised of phenotypically distinct subsets, and exhibit tissue‐specific subset distribution. We developed a flow cytometry (FC) panel for NK‐cell immunophenotypic analysis and clonality
Valerie Woodings, Orrin Koepke, Jason E. Love, Alireza Torabi, Lianqun Qiu, Jonathan R. Fromm, Sindhu Cherian, Afshin Shameli   +7 more
wiley   +1 more source

Late and very late relapsed acute lymphoblastic leukemia: clinical and molecular features, and treatment outcomes

Blood Cancer Journal, 2021
Ibrahim Aldoss, Raju Pillai, Dongyun Yang, Lixin Yang, Shukaib Arslan, Sally Mokhtari, Monzr M. Al Malki, Amandeep Salhotra, Shilpa Shahani, Haris Ali, Matthew Mei, Andrew Artz, David Snyder, Michelle Afkhami, Saro Armenian, Anthony Stein, Guido Marcucci, Stephen J. Forman, Ryotaro Nakamura, Vinod Pullarkat   +19 more
doaj   +1 more source

Fear of Cancer Recurrence in Hematopoietic Cell Transplantation Survivors. [PDF]

Transplant Cell Ther
Liang EC, Shen MJ, Salit RB, Onstad L, Vo P, Oshima MU, Boiko JR, Lee CJ, Carpenter PA, Gauthier J, Simard S, Lee SJ.   +11 more
europepmc   +1 more source

Biomarkers of lung congestion and injury in acute heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 781-789, April 2025.
Abstract Acute heart failure (AHF) classification and management are primarily based on lung congestion and/or hypoperfusion. The quantification of the vascular and tissue lung damage is not standard practice though biomarkers of lung injury may play a relevant role in this context.
Marco Guazzi, Gabriele Novello, Francesca Bursi, Anna Caretti, Noemi Furlotti, Ross Arena, Paola Argiento, Julio Núñez, Antoni Bayes‐Genis, Marco Metra   +9 more
wiley   +1 more source

The Diagnostic Approach to Pulmonary Complications in Allogeneic Hematopoietic Cell Transplantation: To Biopsy or Not? [PDF]

Transpl Infect Dis
Tio SY, Yong MK, Worth LJ.
europepmc   +1 more source

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

ESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli, François Roubille, Nicolas Meyer, Giulio Pompilio, Lionel Leroux, Philippe Henon, Guillaume Trebuchet, Anthony Criquet, Matthieu de Kalbermatten, Eric Saloux, Alain Manrique, Pierre‐Yves Marie, Deepak L. Bhatt, Scott D. Solomon, Gilles Montalescot, David E. Newby, Faiez Zannad, on behalf of the EXCELLENT Trial Investigators   +17 more
wiley   +1 more source